cardiac biomarkers for immune checkpoint inhibitor-related myocarditis in cancer patients
Published 2 months ago • 118 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
2:01
predict response to immune checkpoint inhibition in acute myeloid leukemia (aml) using biomarkers
-
0:52
monitoring, diagnosing & managing cardiotoxicity in al amyloidosis
-
2:07
the potential biomarkers of interest in immune effector cell-associated hlh following car-t
-
2:30
biomarkers of cardiotoxicity in multiple myeloma
-
0:59
mitigating cardiological toxicities associated with btki in b-cell malignancies
-
22:48
cardiac troponins and checkpoint inhibitors
-
2:29
the measurement of molecular biomarkers to aid cll treatment
-
1:52
single-cell and immune sequencing to predict response and resistance to car-t therapy in r/r mm
-
4:04
immune-mediated mechanisms in checkpoint inhibitor-induced myocarditis
-
48:55
jacc: cardiooncology video case presentation | early immune checkpoint inhibitor cardiotoxicity
-
0:59
identifying molecular markers for the prediction of icaht in patients receiving car t-cell therapy
-
0:43
the development of a composite comorbidity index to predict car-t outcomes in patients with dlbcl
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
1:38
feasibility study of computer vision for quantifying cardiac amyloid burden in biopsies
-
1:45
how should we utilizing molecular data to improve all treatment?
-
2:35
inflammatory biomarkers as predictors of car-t efficacy in multiple myeloma
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment